Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

HCWB

HCW Biologics (HCWB)

HCW Biologics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:HCWB
DateTimeSourceHeadlineSymbolCompany
02/11/20254:54PMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:HCWBHCW Biologics Inc
02/07/20254:45PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:HCWBHCW Biologics Inc
02/03/20257:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:HCWBHCW Biologics Inc
02/03/20257:15AMGlobeNewswire Inc.HCW Biologics Granted FDA Clearance to Evaluate One of the Company’s Lead Product Candidates in a First-In-Human Phase 1 Clinical TrialNASDAQ:HCWBHCW Biologics Inc
01/15/20257:00AMGlobeNewswire Inc.HCW Biologics’ Founder and CEO to Address Opportunities and Challenges in Biomanufacturing for Cell and Gene Therapies During J.P. Morgan Week in San Francisco on January 15, 2025NASDAQ:HCWBHCW Biologics Inc
12/23/20248:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:HCWBHCW Biologics Inc
12/23/20248:10AMGlobeNewswire Inc.HCW Biologics Inc. Received NASDAQ Staff Determination LetterNASDAQ:HCWBHCW Biologics Inc
12/05/20244:37PMEdgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:HCWBHCW Biologics Inc
11/22/20244:53PMEdgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:HCWBHCW Biologics Inc
11/22/20244:45PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:HCWBHCW Biologics Inc
11/20/20244:42PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:HCWBHCW Biologics Inc
11/20/202412:54PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NASDAQ:HCWBHCW Biologics Inc
11/18/20249:27PMGlobeNewswire Inc.HCW Biologics Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ RulesNASDAQ:HCWBHCW Biologics Inc
11/18/20247:00AMGlobeNewswire Inc.HCW Biologics and WY Biotech Announce License Agreement for Immunotherapeutic Product CandidateNASDAQ:HCWBHCW Biologics Inc
11/18/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:HCWBHCW Biologics Inc
11/14/20245:14PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HCWBHCW Biologics Inc
11/14/20245:13PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:HCWBHCW Biologics Inc
11/14/20244:40PMGlobeNewswire Inc.HCW Biologics Reports Third Quarter 2024 Financial Results and Business HighlightsNASDAQ:HCWBHCW Biologics Inc
09/20/20245:25PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:HCWBHCW Biologics Inc
08/23/20244:35PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:HCWBHCW Biologics Inc
08/23/20244:30PMGlobeNewswire Inc.HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights - CorrectionNASDAQ:HCWBHCW Biologics Inc
08/14/20244:45PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HCWBHCW Biologics Inc
08/14/20244:40PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:HCWBHCW Biologics Inc
08/14/20244:35PMGlobeNewswire Inc.HCW Biologics Reports Second Quarter 2024 Financial Results and Business HighlightsNASDAQ:HCWBHCW Biologics Inc
08/12/20244:35PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:HCWBHCW Biologics Inc
07/18/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:HCWBHCW Biologics Inc
06/17/20244:57PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HCWBHCW Biologics Inc
06/17/20244:33PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:HCWBHCW Biologics Inc
05/20/20244:36PMEdgar (US Regulatory)Form ARS/A - Annual Report to Security Holders: [Amend]NASDAQ:HCWBHCW Biologics Inc
05/15/20245:21PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HCWBHCW Biologics Inc
 Showing the most relevant articles for your search:NASDAQ:HCWB